• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

IGF2BP3 促进乳酸生成以加速胃癌免疫逃逸。

IGF2BP3 boosts lactate generation to accelerate gastric cancer immune evasion.

机构信息

Department of Gastrointestinal Surgery, Sichuan Academy of Medical Sciences, People's Hospital of Sichuan Provincial, Chengdu, 610101, Sichuan Province, China.

出版信息

Apoptosis. 2024 Dec;29(11-12):2147-2160. doi: 10.1007/s10495-024-02020-w. Epub 2024 Oct 13.

DOI:10.1007/s10495-024-02020-w
PMID:39397122
Abstract

The CD8 T cells mediated antitumor immunity plays a critical function on gastric cancer (GC) immunotherapy. However, the mechanism of N-methyladenosine (mA) and lactate in GC immune microenvironment are still unclear. Here, present research investigated the role of Insulin like growth factor II mRNA binding protein 3 (IGF2BP3) in GC and its in-depth mechanisms in the antitumor immunity. Data illustrated that high IGF2BP3 level was associated to GC poor prognosis and tumor infiltration. Functional assays demonstrated that IGF2BP3 overexpression could promote the lactate accumulation, and impair the CD8 T cells' antitumor immunity activity in co-culture system. Correspondingly, IGF2BP3 silencing enhanced the CD8 T cells' antitumor immunity activity towards co-cultured GC cells. Mechanistically, IGF2BP3 could bind the mA site on LDHA mRNA, thereby promoting its mRNA stability. Rescue assays elucidated that IGF2BP3/LDHA axis impaired the CD8 T cells antitumor immunity by triggering lactate excess tumor microenvironment. In conclusion, our findings demonstrate that IGF2BP3 impairs the CD8 T cells antitumor immunity by targeting LDHA/lactate axis, providing a novel therapeutic insight for GC immunotherapy.

摘要

CD8 T 细胞介导的抗肿瘤免疫在胃癌(GC)免疫治疗中起着关键作用。然而,N-甲基腺苷(m6A)和乳酸在 GC 免疫微环境中的作用机制尚不清楚。本研究探讨了胰岛素样生长因子 II mRNA 结合蛋白 3(IGF2BP3)在 GC 中的作用及其在抗肿瘤免疫中的深入机制。数据表明,IGF2BP3 水平高与 GC 预后不良和肿瘤浸润有关。功能分析表明,IGF2BP3 过表达可促进乳酸积累,并在共培养系统中损害 CD8 T 细胞的抗肿瘤免疫活性。相应地,IGF2BP3 沉默增强了 CD8 T 细胞对共培养 GC 细胞的抗肿瘤免疫活性。在机制上,IGF2BP3 可以结合 LDHA mRNA 上的 mA 位点,从而促进其 mRNA 稳定性。挽救实验表明,IGF2BP3/LDHA 轴通过触发乳酸过多的肿瘤微环境来损害 CD8 T 细胞的抗肿瘤免疫。总之,我们的研究结果表明,IGF2BP3 通过靶向 LDHA/乳酸轴损害 CD8 T 细胞的抗肿瘤免疫,为 GC 免疫治疗提供了新的治疗思路。

相似文献

1
IGF2BP3 boosts lactate generation to accelerate gastric cancer immune evasion.IGF2BP3 促进乳酸生成以加速胃癌免疫逃逸。
Apoptosis. 2024 Dec;29(11-12):2147-2160. doi: 10.1007/s10495-024-02020-w. Epub 2024 Oct 13.
2
METTL3 inhibition restores PD-L1 expression and CD8+ T-cell cytotoxic function in immunotherapy treated gastric cancer.METTL3抑制可恢复免疫治疗的胃癌中PD-L1表达和CD8 + T细胞的细胞毒性功能。
Cancer Immunol Res. 2025 Apr 29. doi: 10.1158/2326-6066.CIR-24-1179.
3
Metabolic alterations driven by LDHA in CD8 + T cells promote immune evasion and therapy resistance in NSCLC.乳酸脱氢酶A(LDHA)驱动的CD8 + T细胞代谢改变促进非小细胞肺癌(NSCLC)的免疫逃逸和治疗抵抗。
Sci Rep. 2025 Jul 8;15(1):24440. doi: 10.1038/s41598-025-87361-5.
4
Multi-omics analysis unveils the predictive value of IGF2BP3/SPHK1 signaling in cancer stem cells for prognosis and immunotherapeutic response in muscle-invasive bladder cancer.多组学分析揭示了 IGF2BP3/SPHK1 信号在肌层浸润性膀胱癌肿瘤干细胞中对预后和免疫治疗反应的预测价值。
J Transl Med. 2024 Oct 4;22(1):900. doi: 10.1186/s12967-024-05685-8.
5
Regulation of the CD8⁺ T cell and PDL1/PD1 axis in gastric cancer: Unraveling the molecular landscape.胃癌中CD8⁺T细胞与PDL1/PD1轴的调控:解析分子格局
Crit Rev Oncol Hematol. 2025 Aug;212:104750. doi: 10.1016/j.critrevonc.2025.104750. Epub 2025 Apr 28.
6
Identification of a stromal immunosuppressive barrier orchestrated by SPP1/C1QC macrophages and CD8 exhausted T cells driving gastric cancer immunotherapy resistance.鉴定由SPP1/C1QC巨噬细胞和CD8耗竭性T细胞共同构成的基质免疫抑制屏障,其驱动胃癌免疫治疗耐药性。
Front Immunol. 2025 Jul 16;16:1618591. doi: 10.3389/fimmu.2025.1618591. eCollection 2025.
7
IGF2BP3 promotes autophagy-mediated TNBC metastasis via m6A-dependent, cap-independent c-Met translation.胰岛素样生长因子2 mRNA结合蛋白3通过m6A依赖的、不依赖帽结构的c-Met翻译促进自噬介导的三阴性乳腺癌转移。
Cell Commun Signal. 2025 Jul 1;23(1):303. doi: 10.1186/s12964-025-02316-7.
8
The N6-methyladenosine reader IGF2BP3 promotes bladder cancer progression through enhancing HSP90AB1 expression.N6-甲基腺苷阅读器IGF2BP3通过增强HSP90AB1的表达促进膀胱癌进展。
FEBS J. 2025 Jul;292(13):3477-3493. doi: 10.1111/febs.70068. Epub 2025 Mar 19.
9
Activation and antitumor immunity of CD8 T cells are supported by the glucose transporter GLUT10 and disrupted by lactic acid.CD8 T 细胞的激活和抗肿瘤免疫受葡萄糖转运蛋白 GLUT10 的支持,并受到乳酸的破坏。
Sci Transl Med. 2024 Aug 28;16(762):eadk7399. doi: 10.1126/scitranslmed.adk7399.
10
N-methyladenosine-regulated exosome biogenesis orchestrates an immunosuppressive pre-metastatic niche in gastric cancer peritoneal metastasis.N-甲基腺苷调节的外泌体生物合成在胃癌腹膜转移中协调形成免疫抑制性的前转移微环境。
Cancer Commun (Lond). 2025 Aug;45(8):941-965. doi: 10.1002/cac2.70034. Epub 2025 May 15.

引用本文的文献

1
Crosstalk between lactylation and RNA modifications in tumorigenesis: mechanisms and therapeutic implications.肿瘤发生过程中乳酸化与RNA修饰之间的相互作用:机制及治疗意义
Biomark Res. 2025 Aug 26;13(1):110. doi: 10.1186/s40364-025-00824-9.
2
Dual role of lncRNA OTUD6B-AS1 in immune evasion and ferroptosis resistance: A prognostic and therapeutic biomarker in breast cancer.长链非编码RNA OTUD6B-AS1在免疫逃逸和铁死亡抗性中的双重作用:乳腺癌的一种预后和治疗生物标志物
Noncoding RNA Res. 2025 Jun 17;14:156-165. doi: 10.1016/j.ncrna.2025.06.002. eCollection 2025 Oct.
3
Tumor Microenvironment Lactate: Is It a Cancer Progression Marker, Immunosuppressant, and Therapeutic Target?

本文引用的文献

1
The RNA mA reader IGF2BP3 regulates NFAT1/IRF1 axis-mediated anti-tumor activity in gastric cancer.RNA mA 阅读器 IGF2BP3 调节胃癌中 NFAT1/IRF1 轴介导的抗肿瘤活性。
Cell Death Dis. 2024 Mar 6;15(3):192. doi: 10.1038/s41419-024-06566-0.
2
IGF2BP3 enhances lipid metabolism in cervical cancer by upregulating the expression of SCD.IGF2BP3通过上调SCD的表达增强宫颈癌中的脂质代谢。
Cell Death Dis. 2024 Feb 14;15(2):138. doi: 10.1038/s41419-024-06520-0.
3
Inhibiting the mA Reader IGF2BP3 Suppresses Ovarian Cancer Cell Growth via Regulating PLAGL2 mRNA Stabilization.
肿瘤微环境中的乳酸:它是癌症进展标志物、免疫抑制剂和治疗靶点吗?
Molecules. 2025 Apr 15;30(8):1763. doi: 10.3390/molecules30081763.
4
The roles of lactate and the interplay with mA modification in diseases.乳酸盐的作用及其在疾病中与甲基化修饰的相互作用。
Cell Biol Toxicol. 2024 Dec 2;40(1):107. doi: 10.1007/s10565-024-09951-9.
抑制 mA 阅读器 IGF2BP3 通过调节 PLAGL2 mRNA 稳定性抑制卵巢癌细胞生长。
World J Oncol. 2024 Feb;15(1):100-113. doi: 10.14740/wjon1747. Epub 2024 Jan 10.
4
Gastric cancer and mesenchymal stem cell-derived exosomes: from pro-tumorigenic effects to anti-cancer vehicles.胃癌与间充质干细胞衍生的外泌体:从促肿瘤生成作用到抗肿瘤载体。
Arch Pharm Res. 2024 Jan;47(1):1-19. doi: 10.1007/s12272-023-01477-8. Epub 2023 Dec 27.
5
The combination of soluble forms of PD-1 and PD-L1 as a predictive marker of PD-1 blockade in patients with advanced cancers: a multicenter retrospective study.可溶性 PD-1 和 PD-L1 联合作为预测晚期癌症患者 PD-1 阻断疗效的标志物:一项多中心回顾性研究。
Front Immunol. 2023 Dec 11;14:1325462. doi: 10.3389/fimmu.2023.1325462. eCollection 2023.
6
Application of artificial intelligence in endoscopic gastrointestinal tumors.人工智能在胃肠道内镜肿瘤中的应用。
Front Oncol. 2023 Dec 6;13:1239788. doi: 10.3389/fonc.2023.1239788. eCollection 2023.
7
IGF2BP3-mediated regulation of and gene expression promotes treg-induced immune escape in human cervical cancer.IGF2BP3介导的 和 基因表达调控促进人宫颈癌中调节性T细胞诱导的免疫逃逸。 (注:原文中“和”前面的部分缺失,你可补充完整后再让我准确翻译)
Am J Cancer Res. 2023 Nov 15;13(11):5289-5305. eCollection 2023.
8
The m6A reader IGF2BP3 preserves NOTCH3 mRNA stability to sustain Notch3 signaling and promote tumor metastasis in nasopharyngeal carcinoma.m6A 阅读器 IGF2BP3 可维持 NOTCH3 mRNA 的稳定性,从而促进鼻咽癌中 Notch3 信号的激活和肿瘤转移。
Oncogene. 2023 Nov;42(48):3564-3574. doi: 10.1038/s41388-023-02865-6. Epub 2023 Oct 18.
9
Targeting IGF2BP3 in Cancer.靶向 IGF2BP3 治疗癌症。
Int J Mol Sci. 2023 May 29;24(11):9423. doi: 10.3390/ijms24119423.
10
Oncofetal protein IGF2BPs in human cancer: functions, mechanisms and therapeutic potential.人癌症中的癌胚蛋白IGF2BPs:功能、机制及治疗潜力
Biomark Res. 2023 Jun 6;11(1):62. doi: 10.1186/s40364-023-00499-0.